EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 177 filers reported holding EVOLENT HEALTH INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,387,603 | +8.0% | 124,407 | +28.7% | 0.00% | 0.0% |
Q2 2023 | $3,137,103 | 0.0% | 96,675 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,137,103 | +30.3% | 96,675 | +12.7% | 0.00% | +100.0% |
Q4 2022 | $2,407,804 | -99.9% | 85,748 | +1.4% | 0.00% | -50.0% |
Q3 2022 | $3,037,630,000 | -10.5% | 84,543 | -23.5% | 0.00% | 0.0% |
Q2 2022 | $3,394,130,000 | -0.5% | 110,522 | +4.6% | 0.00% | +100.0% |
Q1 2022 | $3,412,365,000 | +30.4% | 105,646 | +11.7% | 0.00% | 0.0% |
Q4 2021 | $2,617,334,000 | +6.5% | 94,591 | +19.3% | 0.00% | 0.0% |
Q3 2021 | $2,457,339,000 | +44.5% | 79,269 | -1.6% | 0.00% | 0.0% |
Q2 2021 | $1,700,561,000 | +8.9% | 80,519 | +4.1% | 0.00% | 0.0% |
Q1 2021 | $1,561,805,000 | +28.1% | 77,317 | +1.7% | 0.00% | 0.0% |
Q4 2020 | $1,218,921,000 | +29.2% | 76,040 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $943,656,000 | +71.7% | 76,040 | -1.5% | 0.00% | – |
Q2 2020 | $549,649,000 | +47.5% | 77,198 | +12.5% | 0.00% | – |
Q1 2020 | $372,672,000 | -45.0% | 68,632 | -8.3% | 0.00% | – |
Q4 2019 | $677,012,000 | +25.0% | 74,808 | -0.7% | 0.00% | – |
Q3 2019 | $541,580,000 | +22.4% | 75,324 | +35.3% | 0.00% | – |
Q2 2019 | $442,465,000 | -30.3% | 55,656 | +10.3% | 0.00% | – |
Q1 2019 | $634,825,000 | -95.2% | 50,463 | -92.4% | 0.00% | -100.0% |
Q4 2018 | $13,249,792,000 | -33.9% | 664,150 | -5.9% | 0.01% | -26.7% |
Q3 2018 | $20,041,142,000 | +40.8% | 705,674 | +4.3% | 0.02% | +36.4% |
Q2 2018 | $14,238,620,000 | +36.7% | 676,419 | -7.5% | 0.01% | +37.5% |
Q1 2018 | $10,415,525,000 | +12.6% | 730,914 | -2.8% | 0.01% | 0.0% |
Q4 2017 | $9,248,370,000 | -32.6% | 751,900 | -2.4% | 0.01% | -33.3% |
Q3 2017 | $13,719,581,000 | -4.2% | 770,763 | +36.4% | 0.01% | -14.3% |
Q2 2017 | $14,322,775,000 | +6.9% | 565,001 | -5.9% | 0.01% | 0.0% |
Q1 2017 | $13,392,533,000 | +3629312.7% | 600,562 | +3903.7% | 0.01% | – |
Q3 2016 | $369,000 | +35.2% | 15,000 | +5.6% | 0.00% | – |
Q2 2016 | $273,000 | -24.2% | 14,200 | -58.3% | 0.00% | – |
Q1 2016 | $360,000 | -78.2% | 34,045 | -75.0% | 0.00% | -100.0% |
Q4 2015 | $1,651,000 | -29.7% | 136,335 | -7.3% | 0.00% | -33.3% |
Q3 2015 | $2,347,000 | -45.9% | 147,073 | -33.9% | 0.00% | -25.0% |
Q2 2015 | $4,341,000 | – | 222,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Voce Capital Management LLC | 323,694 | $9,807,928 | 16.97% |
Engaged Capital LLC | 1,747,252 | $52,941,736 | 7.66% |
Greenhouse Funds LLLP | 1,399,260 | $42,397,578 | 3.31% |
Rock Point Advisors, LLC | 330,448 | $10,012,574 | 3.29% |
FORMULA GROWTH LTD | 299,510 | $9,075,153 | 2.89% |
Rock Springs Capital Management LP | 3,803,500 | $115,246,050 | 2.74% |
Granahan Investment Management | 2,914,350 | $88,304,805 | 2.72% |
SECTORAL ASSET MANAGEMENT INC | 488,142 | $14,790,703 | 2.47% |
Summit Creek Advisors LLC | 557,070 | $16,879,221 | 2.11% |
Orbimed Advisors | 2,895,632 | $87,737,650 | 1.59% |